Keypoint34

Looking around for investment ideas

[Keypoint34 @keypoint34]

$iova had great earning. Tempting to take profits (never a terrible idea) but lung data, updated rev #s, more centres, cash until at least 2028.. maybe buying MORE is the better idea

[Keypoint34 @keypoint34]

@HE4DEYES @RealPeterLinder He needed to get out before telling others to get out…

[Keypoint34 @keypoint34]

@CapExNick @Heatlamp11 Oh wait, just for amtagvi (not total rev)….that sounds dang good and probs correct!

[Keypoint34 @keypoint34]

@CapExNick @Heatlamp11 Minimum…😄

[Keypoint34 @keypoint34]

@gio_armani @faktenbasis $iova year end target, for me it is $13…more with a squeeze or really good lung data

[Keypoint34 @keypoint34]

@imanobo02670922 I was just saying that no special dividend announced for HME.V was disappointing

[Keypoint34 @keypoint34]

$hme.v $hme.ne earning Thursday, I am looking for another special dividend of .03 and hopefully some growth in barrels/day

[Keypoint34 @keypoint34]

@imanobo02670922 Well dang…good luck!

[Keypoint34 @keypoint34]

@Rekt_Zerker You haven't heard of $IOVA huh? Lung cancer next...approved for 2nd line melanoma already...check it out

[Keypoint34 @keypoint34]

@YodaStockInvest $iova watch and learn....

[Keypoint34 @keypoint34]

$mrna awesome stuff, though I am pretty sure $iova also has a tumor cancer drug that works…TIL baby

[Keypoint34 @keypoint34]

@DeuceCabooseSki $iova correction: with guidance currently 350-370 million rev, I think they raise it to 370-400 million 🤦

[Keypoint34 @keypoint34]

@DeuceCabooseSki $iova Oh, it will come. I think it will be raised a conservative 30 million (10%ish, from 370-400 million to 400-430 million) in order to leave room for a Q3 beat. Announcement will be sept 9th, if I had to guess.

[Keypoint34 @keypoint34]

@Dancingtapas @DeuceCabooseSki My bad, Ty! (It was late I should have double checked)

[Keypoint34 @keypoint34]

@GeertLangenus @OldGoldHawkeye @jy201506 @Dancingtapas @jfais20 They said they would update 2H guidance in Q3...not after Q3 at earnings (which would be Q4).

[Keypoint34 @keypoint34]

@OldGoldHawkeye @jy201506 @Dancingtapas @jfais20 $iova good call, except corporate guidance WILL be raised, not IF. They will announce by how much in the next 6 weeks. I am hopeful for a 10-15% bump in both guidance and share price (when announced)

[Keypoint34 @keypoint34]

@stockplaymaker1 But this is an actual life saving technology that is a good investment...not a pump and dump...Lung cancer trial ongoing with melanoma already approved

[Keypoint34 @keypoint34]

@stockplaymaker1 $IOVA only it is a next 2 year swing with all the catalysts upcoming...B.O. target is $20-35/share by end of 2028

[Keypoint34 @keypoint34]

@unnatural78 @DeuceCabooseSki @Henry431171040 He (CM61) already stated that he would get back in at $5 or the high 4s after earnings (then he called me some names). Stock Just hit $7…so you are missing out. I’d get back in as I don’t think we see $5/share ever again $iova

[Keypoint34 @keypoint34]

@Rfunk819 @DeuceCabooseSki Just hit $7. I know it feels like one you’ve ‘missed’ already. But look up the incoming catalysts over the next year…I think we are still ‘cheap’ (I bought more today)

[Keypoint34 @keypoint34]

@DeuceCabooseSki @kel_nguy They have 300 million in cash, own their own manufacturing facility…great balance sheet, they just are not profitable yet (like most early stage bio companies). Lung cancer trial will add 7x to rev potential (which is eat a 1 billion currently)